Additionally, by integrating machine learning, we analyze the combined impact of HDL subpopulations (α-1, α-2, and preβ-1 HDL), inflammatory biomarkers (MPO, SAA), and small dense LDL, providing a more refined and data-driven approach to CHD risk stratification. The gene discussed is MPO; the disease is coronary artery disorder.